Advancy served as strategic vendor due diligence advisor to Tilia Holdings during the recapitalization of NutriScience Innovations by Frontenac.

This strategic transaction marks a decisive milestone for NutriScience Innovations as it enters its next phase of accelerated growth in the global health and wellness market.

Strategic Advisory for High-Impact Transactions

In the rapidly evolving health and wellness sector, science-backed solutions and market foresight are essential for long-term growth. Advancy provided comprehensive strategic vendor due diligence to support Tilia Holdings and highlight the core value drivers of NutriScience Innovations.

Supporting the Next Phase of Growth

With the support of Frontenac and Tilia Holdings, NutriScience Innovations is uniquely positioned to expand its product development capabilities and bring next-generation wellness ingredients to market.

At Advancy, we take pride in delivering actionable insights that help private equity firms and industry leaders execute seamless, high-value transactions. Congratulations to the teams at Tilia Holdings, NutriScience Innovations, and Frontenac on this successful deal!

Partner with Our Strategy Experts

Looking to navigate complex strategic transactions or unlock sustainable value in your portfolio?

Discover our strategy & private equity expertise